Memorándum de análisis químico y toxicología para la licenciatura y el doctorado en Medicina y Farmacia

Memorándum de análisis químico y toxicología para la licenciatura y el doctorado en Medicina y Farmacia PDF Author:
Publisher:
ISBN:
Category :
Languages : es
Pages : 259

Get Book Here

Book Description


Memorándum de química para la licenciatura y el doctorado en Farmacia

Memorándum de química para la licenciatura y el doctorado en Farmacia PDF Author:
Publisher:
ISBN:
Category :
Languages : es
Pages : 298

Get Book Here

Book Description


Memorandum de Análisis químico y Toxicología

Memorandum de Análisis químico y Toxicología PDF Author: Ludovic Jammes
Publisher:
ISBN:
Category :
Languages : es
Pages :

Get Book Here

Book Description


Tratado de análisis químico

Tratado de análisis químico PDF Author: R. Casares López
Publisher:
ISBN:
Category :
Languages : es
Pages : 0

Get Book Here

Book Description


Memorándum de terapéutica de materia médica y de farmacología...

Memorándum de terapéutica de materia médica y de farmacología... PDF Author: Paul Lefert
Publisher:
ISBN:
Category :
Languages : es
Pages : 286

Get Book Here

Book Description


Tratado de análisis químico

Tratado de análisis químico PDF Author: Román Casares López
Publisher:
ISBN: 9788460056089
Category :
Languages : es
Pages : 507

Get Book Here

Book Description


Pollution of Water Bodies in Latin America

Pollution of Water Bodies in Latin America PDF Author: Leobardo Manuel Gómez-Oliván
Publisher: Springer
ISBN: 9783030272951
Category : Science
Languages : en
Pages : 0

Get Book Here

Book Description
The indiscriminate use of chemical substances in industrial processes and anthropogenic activities, have resulted in the release of these compounds into aquatic ecosystems through municipal, hospital and industrial discharges, producing various undesired effects on the environment and on species of ecological interest. These compounds, such as metals, pesticides, emerging pollutants and other substances are persistent and susceptible to biotic and/or abiotic transformations, yielding metabolites that can be more toxic than the original compounds. In this book, researchers from diverse environmental science disciplines share their experiences in countries such as Argentina, Brazil, Colombia and Mexico, and critically examine the problem of contaminants in aquatic ecosystems in Latin America, as well as the risks presented by their presence.

An Introduction to Pharmacovigilance

An Introduction to Pharmacovigilance PDF Author: Patrick Waller
Publisher: John Wiley & Sons
ISBN: 1119289742
Category : Medical
Languages : en
Pages : 194

Get Book Here

Book Description
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. This introductory guide is designed to aid the rapid understanding of the key principles of pharmacovigilance. Packed full of examples illustrating drug safety issues it not only covers the processes involved, but the regulatory aspects and ethical and societal considerations of pharmacovigilance. Covering the basics step-by-step, this book is perfect for beginners and is essential reading for those new to drug safety departments and pharmaceutical medicine students. The second edition is thoroughly revised and updated throughout and includes a new chapter on clinical aspects of pharmacovigilance.

Medicines For Women

Medicines For Women PDF Author: Mira Harrison-Woolrych
Publisher: Springer
ISBN: 3319124064
Category : Medical
Languages : en
Pages : 624

Get Book Here

Book Description
In this definitive new text, the major medicines, devices and vaccines used by women worldwide are brought together for the first time in a single volume. Written and edited by international experts with an evidence-based approach, the book offers a comprehensive summary of all the key areas of women’s medicines. In the first part, issues relating to female drug exposure and considerations for prescribing for subgroups of women - for example during pregnancy and lactation - are presented in the context of contemporary clinical practice. In the second part, specific groups of pharmaceutical products are reviewed, including oral contraceptives, emergency contraception, treatment of chronic pelvic pain, hormone replacement therapy, bisphosphonates, herbal medicines for women, contraceptive devices and human papilloma virus (HPV) vaccines. Every chapter reviews and summarises the efficacy and safety of each group of products and concludes with a useful set of clinical take home messages. In the third part, broader perspectives are presented - from a primary care overview of prescribing for women, through to regulatory, political and religious aspects, including issues with women’s medicines in developing countries. The final two chapters focus on risk communication and conclude that women themselves should be placed at the centre of all discussions about their medicines. The book is aimed at prescribers, other healthcare professionals and students in the field of women’s health throughout the world. It is an extremely valuable resource for all in clinical practice, for students of medicine, nursing, pharmacy and related sciences, and also for those in medicines regulation, pharmacovigilance and the pharmaceutical industry.

Practical Approaches to Risk Minimisation for Medicinal Products

Practical Approaches to Risk Minimisation for Medicinal Products PDF Author: World Health Organization
Publisher:
ISBN: 9789290360841
Category : Drugs
Languages : en
Pages : 0

Get Book Here

Book Description
Risk management of medicines is a wide and rapidly evolving concept and practice, following a medicine throughout its lifecycle, from first administration in humans through clinical studies and then marketing in the patient population at large. Previous reports from CIOMS I - VIII provided practical guidance in some essential components of risk management such as terminology and reporting of adverse drug reactions, management of safety information from clinical trials, and safety signal detection. Beyond the detection, identification, and characterization of risk, "risk minimization" is used as an umbrella term for the prevention or mitigation of an undesirable outcome. Risk management always includes tools for "routine risk minimization" such as product information, the format depending on the jurisdiction, to inform the patient and the prescriber, all of which serve to prevent or mitigate adverse effects. Until this current CIOMS IX document, limited guidance has been available on how to determine which risks need "additional risk minimization," select the appropriate tools, apply and implement such tools globally and locally, and measure if they are effective and valuable. Included in the report is a CIOMS framework for the evaluation of effectiveness of risk minimization, a discussion of future trends and developments, an annex specifically addressing vaccines, and examples from real life.